Expect a Limited Role for the New HIV Drug, Juluca
Juluca (jah-LOO-kah, dolutegravir/rilpivirine) will be the first two-drug combo that's a COMPLETE treatment regimen for HIV.
Most patients use THREE meds to treat HIV...often two nucleoSIDE/ nucleoTIDE reverse transcriptase inhibitors (NRTIs) PLUS another antiretroviral from a different class.
Juluca doesn't have an NRTI. It combines the integrase inhibitor, dolutegravir (Tivicay), with the NON-nucleoside reverse transcriptase inhibitor, rilpivirine (Edurant). It's a single tablet taken once daily.